The new company aims to combine with a healthcare or life sciences business facing value-driving milestones in the next 12-24 months. Ignyte is led by Chairman and Co-CEO David I. Rosenberg alongside Co-CEO David J. Strupp and CFO Steven Kaplan.
Total SPAC deal count for 2021 year-to-date is now 82 with $22.8 billion in gross proceeds raised. This offering is expected to close on Monday, February 1.
EarlyBirdCapital, Inc. is serving as the sole book-running manager for the offering. Graubard Miller is serving as Issuer’s Counsel with Greenberg Traurig LLP serving as Underwriter’s Counsel. Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.